Document Xrre7gp0V4qOEXqennVEY3od
To: From: Gc: Bcc: Received Date: Subject:
Gagen, Stuart Z SHLOIL-SHOIL-SHS <stuart.cagen@shell.com> r.jeffrey.lewis@exxonmobil.com <r.jeffrey.lewis@exxonmobil.com>
2006-01-24 19:25:27 GMT RE: Action Items for Peer Review List Development - Please read and act
Stuart,
I've also forwarded this email to Michael and Rob but haven't seen any response. I'll try to stop by their offices and see if they have suggestions.
Jeff
R. Jeffrey Lewis ExxonMobil Biomedical Sciences, Inc. Epidemiology & Health Surveillance Section 1545 Route 22 East, P.O. Box 971 Room LF 264 Annandale, NJ 08801-0971 (908)730-1107 (voice) (908)730-1192 (fax) (732)437-0670 (pager) r.jeffrey.lewis@exxonmobil.com
This document and all information contained within this electronic message may be privileged, confidential, and exempt from disclosure under applicable law. It is intended only for the use of the individual(s) and/or entity(ies) named above. If you are not the intended recipient, you are on notice that any unauthorized disclosure, copying, distribution, or taking of any action in reliance on the contents of the electronically transmitted materials is prohibited.
"Gagen, Stuart
Z
SHLOIL-SHOIL-S
To
HS" <michael.g.bird@exxonmobil.com>,
<stuart.cagen@
<r.jeffrey.lewis@exxonmobil.com>,
shell.com>
<a.r.schnatter@exxonmobil.com>
cc
01/19/0607:54
Subject
PM RE: Action Items for Peer Review
List Development - Please read and
act
SH ELL-MCCLU RG-055040
As per actions for Jeff:
I think one action was to ask Rob and Michael about potential peer reviewers who are now members of the Shanghai Science Review Panel.
Stuart Cagen
Shell Health Services One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916
Tel: +1 713241 1407 Fax: 3325 Other Tel: +1 8326463987 Email: stuart.cagen@shell.com Internet: http://www.shell.com/chemicals
"Business Success through HSSE Excellence"
-----Original Message----From: Elizabeth_Moran@americanchemistry.com [mailto: Elizabeth_Moran@americanchemistry.coml Sent: Thursday, January 19, 20065:52 PM To: Cagen, Stuart Z SHLOIL-SHOIL-SHS; david.dutton@innovene.com; Ray-Papciak @huntsman. com; Ipottenger@dow.com; william. rawson@ Iw. com; Marcy. Banton@ Lyondell. com; mwlej m @aol.com; Shelby-Jones@americanchemistry.com; leeji@cpchem.com; michael.g.bird@exxonmobil.com; r.jeffrey.lewis@exxonmobil.com; a.r.schnatter@exxonmobil.com Subject: Action Items for Peer Review List Development - Please read and act
W. Rawson, E. Moran and S. Cagen will review the final draft risk assessment report prior to transmitting it to the peer review leadership team.
THE FOLLOWING SCIENTISTS WERE IDENTIFIED AS PEER REVIEW NOMINEES:
Harvey Checkoway David Coglin Gary Marshall Tucker? Wayne State University David Eastman? Jefferson Richard Larson? University of Chicago Medical School Helmut Grime? Germany
The follow plan was designed to develop a more complete list of nominated peer reviewers:
L. Pottenger will send contact information for Marshall, Tucker, Eastman and Larson.
SH ELL-MCCLU RG-055041
S. Cagen will send contact information for Checkoway. J. Lewis will consult with M. Bird and provide additional nominations. E. Moran will request suggestions for peer reviewers from the Risk Assessment Team. L. Pottenger will discuss additional scientists with J. Bus. J. Lewis will talk to R. Schnatter about experts in leukemia. E. Moran will compile the list and circulate to the BWG for final review. E. Moran will contact T. Scalli and update him on the status of the risk assessment. W. Rawson will contact L. Hulse regarding the status of the residual risk rule for the HON category. W. Rawson will develop the first draft of possible charge questions to suggest to Sciences International and circulate them for BWG comment. Elizabeth J. Moran, Ph.D. Senior Director American Chemistry Council 1300 Wilson Blvd Arlington, VA 22209 P: 301 924 2006 F: 301 924 1504
SH ELL-MCCLU RG-055042